Sunitinib for advanced renal cell cancer

Chris CoppinBC Cancer Agency and University of British Columbia, Vancouver, CanadaAbstract: Renal cell cancer has been refractory to drug therapy in the large majority of patients. Targeted agents including sunitinib have been intensively evaluated in renal cell cancer over the past 5 years. Sunitin...

Full description

Saved in:
Bibliographic Details
Main Author: Chris Coppin
Format: article
Language:EN
Published: Dove Medical Press 2008
Subjects:
Online Access:https://doaj.org/article/0e56df7e3f4243d8b44f24ffdfe34e51
Tags: Add Tag
No Tags, Be the first to tag this record!